Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMC 269188)

Published in J Clin Microbiol on July 01, 1987

Authors

P H Gilligan, P A Gage, D F Welch, M J Muszynski, K R Wait

Articles citing this

Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev (1991) 7.12

Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation. J Clin Microbiol (2003) 1.71

Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol (2006) 1.45

Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax (1993) 1.37

Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect Immun (2005) 1.35

Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis (2013) 1.34

In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J Bacteriol (2007) 1.27

The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother (2008) 1.26

Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples. J Clin Microbiol (2004) 1.24

Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol (2003) 1.23

Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14

Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol (1992) 1.11

Inactivation of thyA in Staphylococcus aureus attenuates virulence and has a strong impact on metabolism and virulence gene expression. MBio (2014) 1.09

Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect Immun (2007) 0.97

Evaluation of mannitol salt agar for detection of oxacillin resistance in Staphylococcus aureus by disk diffusion and agar screening. J Clin Microbiol (1998) 0.90

Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections. Clin Microbiol Rev (2016) 0.89

Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J Clin Microbiol (2008) 0.88

Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection. J Clin Microbiol (2012) 0.84

Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother (2012) 0.83

Assessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaire. J Clin Microbiol (2014) 0.80

Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge. Antimicrob Agents Chemother (2015) 0.79

Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. Antimicrob Agents Chemother (2009) 0.78

Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria. Curr Microbiol (2016) 0.78

Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection. J Clin Microbiol (2003) 0.76

Multicenter Evaluation of a Modified Cefoxitin Disk Diffusion Method and PBP2a Testing to Predict mecA-mediated oxacillin resistance in atypical Staphylococcus aureus. J Clin Microbiol (2016) 0.75

Articles by these authors

Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82

Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71

A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00

Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20

Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09

Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85

Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74

Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59

Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol (1993) 2.41

Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother (1979) 2.40

Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis (1995) 2.31

Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25

Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24

Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23

Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1993) 2.22

Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20

Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med (1992) 2.20

Relationship between superoxide dismutase and pathogenic mechanisms of Listeria monocytogenes. Infect Immun (1979) 2.15

Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15

Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09

Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.79

Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis (1983) 1.78

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74

Comparison of sedimentation and flotation techniques for identification of Cryptosporidium sp. oocysts in a large outbreak of human diarrhea. J Clin Microbiol (1985) 1.73

The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72

Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol (1984) 1.70

Evaluation of a lysis direct plating method for pediatric blood cultures. J Clin Microbiol (1985) 1.61

Experimental infection of young specific pathogen-free cats with Bartonella henselae. J Infect Dis (1997) 1.61

Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol (1981) 1.56

Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis (1990) 1.54

Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med (2001) 1.52

Survival of human immunodeficiency virus in blood culture systems. Arch Pathol Lab Med (1988) 1.51

Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid. J Clin Microbiol (1982) 1.50

Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49

Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis (1988) 1.42

Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis. J Clin Microbiol (1983) 1.40

Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J Clin Microbiol (1993) 1.39

Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol (1992) 1.34

Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J (1994) 1.34

Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30

Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol (1993) 1.28

Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics (1985) 1.24

Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24

Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol (1994) 1.23

Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur J Clin Microbiol (1987) 1.21

Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19

Capnocytophaga ochracea septicemia. J Clin Microbiol (1981) 1.18

Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli. Infect Immun (1979) 1.18

Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17

Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatr (1985) 1.16

Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol (1995) 1.14

Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant (2000) 1.12

In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12

Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12

Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother (1986) 1.11

Evaluation of the campyslide agglutination test for confirmatory identification of selected Campylobacter species. J Clin Microbiol (1988) 1.09

Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol (1998) 1.08

Absorption of oral vancomycin - possible associated toxicity. Int J Pediatr Nephrol (1983) 1.08

In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07

Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med (1997) 1.04

Clostridium difficile in patients with cystic fibrosis. Am J Dis Child (1985) 1.03

Clostridium difficile peritonitis in a neonate. A case report. Arch Pathol Lab Med (1984) 1.01

Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease. J Clin Microbiol (1990) 1.00

Pertussis is rare in human immunodeficiency virus disease. Am Rev Respir Dis (1993) 1.00

Fasle-positive macroscopic appearance of blood cultures in sorbitol-containing hypertonic medium. J Clin Microbiol (1979) 0.98

Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol (1994) 0.97

Recognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphatase. J Clin Microbiol (1985) 0.96

In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother (1990) 0.95

Cat scratch disease: the rare role of Afipia felis. J Clin Microbiol (1998) 0.94

Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child (1983) 0.93

A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis. Pediatr Pharmacol (New York) (1985) 0.93

Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis (1986) 0.92

Comparison of lysis-direct plating and broth methods for pediatric blood cultures: clinical relevance and cost effectiveness. Pediatr Infect Dis (1985) 0.92

Sputum screening by Nomarski interference contrast microscopy. J Clin Microbiol (1979) 0.91

Campylobacter enteritis. A 3-year experience. Clin Pediatr (Phila) (1984) 0.91

Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J Clin Microbiol (1995) 0.90

Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother (1987) 0.90

Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 0.90

Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr Pulmonol (1997) 0.89

Catalase-negative listeria monocytogenes causing meningitis in an adult. Clinical and laboratory features. Am J Clin Pathol (1991) 0.89

Evaluation of the latex agglutination test for detection of Clostridium difficile. Arch Pathol Lab Med (1992) 0.89

Neutralization of the inhibitory effect of sodium polyanetholesulfonate on Neisseria meningitidis in blood cultures processed with the Du Pont Isolator System. J Clin Microbiol (1984) 0.89

Evaluation of the automated Bact-Alert system for pediatric blood culturing. Am J Clin Pathol (1995) 0.88

Feline mammary carcinoma and progestogens. Feline Pract (1980) 0.87

Morphologically variable bacilli of cat scratch disease are identified by immunocytochemical labeling with antibodies to Rochalimaea henselae. Am J Clin Pathol (1994) 0.86

Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis (1993) 0.86

Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae. Vet Immunol Immunopathol (1999) 0.85

Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds. J Antimicrob Chemother (1997) 0.84

Evaluation of an enzyme immunoassay for detection of Neisseria gonorrhoeae in an adolescent population. JAMA (1984) 0.84

Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia. J Antimicrob Chemother (1997) 0.84

Diagnosis of bacterial infections of the newborn infant. Clin Perinatol (1981) 0.84

Middle ear effusion amoxicillin concentrations in acute otitis media. Pediatr Infect Dis J (1998) 0.83

In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrob Agents Chemother (1984) 0.82

Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. J Pediatr (1986) 0.81